| Literature DB >> 31715685 |
Moran Ki1, Hyunjin Son2, Bo Youl Choi3.
Abstract
The 2019 hepatitis A outbreak has become increasingly prevalent among adults in Korea and is the largest outbreak since that in 2009-2010. The incidence in the current outbreak is highest among adults aged 35-44 years, corresponding to the peak incidence among those aged 25-34 years 10 years ago. This may indicate a cohort effect in the corresponding age group. Causes of these repeated outbreaks of hepatitis A in Korea are low level of immunity among adults, Korean food culture that consumes raw seafood such as salted clam and inadequate public health system. Among countermeasures, along with general infectious disease control measures including control of the infectious agent, infection spread, and host, urgent actions are needed to review the vaccination policy and establish an adequate public health system.Entities:
Keywords: Catch-up; Epidemiology; Hepatitis A virus; Immunization; Outbreak; Public health
Mesh:
Substances:
Year: 2019 PMID: 31715685 PMCID: PMC6883026 DOI: 10.4178/epih.e2019038
Source DB: PubMed Journal: Epidemiol Health ISSN: 2092-7193
Figure 1.Reported cases of hepatitis A in Korea, 2011-2019 (as of October 13, 2019).
Figure 2.Weekly reported cases of hepatitis A in Korea, 2011-2019 (as of 40th week).
Figure 3.Age distribution of reported hepatitis A cases in Korea, 2019 (as of October 13, 2019).
Figure 4.Incidence rate per 100,000 (n) of hepatitis A by area in Korea, 2019 (as of October 13, 2019).
Figure 5.Hepatitis A deaths by year in Korea.
Figure 6.Age distribution of hepatitis A deaths in Korea, 2000-2017.
Area and sex-adjusted seroprevalence (%) of anti-HAV from 2005 to 2014, in Korea[1]
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Subjects (n) | 1,140 | 1,642 | 2,050 | 6,207 | 14,101 | 60,846 | 83,586 | 76,906 | 84,102 | 93,665 | - |
| Age (yr) | |||||||||||
| 0-9 | 33.4 | 52.7 | 42.4 | 50.7 | 69.8 | 65.8 | 53.9 | 71.0 | 65.4 | 67.7 | - |
| 10-19 | 15.4 | 19.0 | 20.0 | 25.5 | 23.2 | 19.0 | 26.4 | 33.8 | 35.4 | 35.2 | 42.1 |
| 20-29 | 22.5 | 29.2 | 19.1 | 17.2 | 11.9 | 8.7 | 13.3 | 16.2 | 16.3 | 20.2 | 12.6 |
| 30-39 | 69.6 | 67.6 | 63.8 | 58.6 | 48.4 | 40.7 | 37.3 | 34.3 | 32.1 | 32.4 | 31.8 |
| 40-49 | 97.9 | 96.7 | 94.7 | 91.4 | 89.1 | 87.9 | 86.1 | 84.1 | 80.8 | 79.3 | 80.3 |
| 50-59 | 98.7[ | 98.2[ | 98.0[ | 99.0[ | 98.8[ | 98.7 | 98.7 | 98.4 | 98.0 | 98.1 | 97.7 |
| 60+ | - | - | - | - | - | 99.2 | 98.1 | 99.3 | 99.5 | 99.6 | - |
| Overall[ | 65.6 | 68.2 | 64.9 | 65.1 | 63.8 | 61.0 | 60.5 | 62.9 | 61.6 | 62.2 | - |
HAV, hepatitis A virus.
Seroprevalence of anti-HAV was adjusted by area from 2005 to 2009 and by area and sex from 2010 to 2014.
From 2005 to 2009, people over 50 years old presented in groups because of the small numbers and similar seroprevalence.
Overall seroprevalence was adjusted by age, area, and/or sex using the 2010 population.
Data sources from: 2005-2014: Kim et al. PLoS One 2017;12:e0170432 [6]; 2015: Lim et al. PLoS One 2017;12:e0189210 [8].